Recent advances in animal virology
著者
書誌事項
Recent advances in animal virology
Springer, c2019
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
"ISBN:9789811390739(eBook)"--T.p.verso
内容説明・目次
内容説明
This book discusses the prominence and implication of the viral diseases that are a major threat to animals around the globe. A number of these diseases have also shown links with human populations, which has implications for public health. This book offers detailed and up-to-date information on viral diseases in livestock and poultry that were and/or are still a problem. Including cutting-edge developments, it also highlights several landmark contributions in the field of virology from India. Additionally, the book features tables and figures showing important clinical data and recommendations, with references for further information. It also explores the economic impact of viral diseases for farmers and the livestock industry, providing several examples. Further, it presents the latest information on viral diseases in global context, with a focus on state-of-art, molecular tools for the development of diagnostics, prophylactics and therapeutics. Lastly, the book also describes the challenges posed by the emerging and transboundary viral infections and our preparedness to counter them.
目次
Module 1_ Introduction.- Module 2_ Pox viruses.- Chapter 2.1. Background.- Chapter 2.2. History.- Chapter 2.3. Incidence and Prevalence.- Chapter 2.4. Diagnostic Techniques.- Chapter 2.5. Risk Factors.- Chapter 2.6. Transmission.- Chapter 2.7. Prevention & Control, References.- Module 3_Herpes viruses.- Chapter 3.1. Background.- Chapter 3.2. History.- Chapter 3.3. Incidence and Prevalence.- Chapter 3.4. Diagnostic Techniques.- Chapter 3.5. Risk Factors.- Chapter 3.6. Transmission.- Chapter 3.7. Prevention & Control, References.- Module 4_Papillomaviruses.- Chapter 4.1. Background.- Chapter 4.2. History.- Chapter 4.3. Incidence and Prevalence.- Chapter 4.4. Diagnostic Techniques.- Chapter 4.5. Risk Factors.- Chapter 4.6. Transmission.- Chapter 4.6. Prevention & Control, References.- Module 5_Adenoviruses.- Chapter 5.1. Background.- Chapter 5.2. History.- Chapter 5.3. Incidence and Prevalence.- Chapter 5.4. Diagnostic Techniques.- Chapter 5.5. Risk Factors.- Chapter 5.6. Transmission.- Chapter 5.7. Prevention & Control, References.- Module 6_Parvoviruses.- Chapter 6.1. Background.- Chapter 6.2. History.- Chapter 6.3.Incidence and Prevalence.- Chapter 6.4. Diagnostic Techniques.- Chapter 6.5. Risk Factors.- Chapter 6.6. Transmission.- Chapter 6.7. Prevention & Control, References.- Module 7_Circoviruses.- Chapter 7.1. Background.- Chapter 7.2. History.- Chapter 7.3. Incidence and Prevalence.- Chapter 7.4. Diagnostic Techniques.- Chapter 7.5. Risk Factors.- Chapter 7.6. Transmission.- Chapter 7.7. Prevention & Control, References.- Module 8_Reoviruses (Orbiviruses, Rotaviruses, Reovirus).- Chapter 8.1. Background.- Chapter 8.2. History.- Chapter 8.3. Incidence and Prevalence.- Chapter 8.4. Diagnostic Techniques.- Chapter 8.5. Risk Factors.- Chapter 8.6. Transmission.- Chapter 8.7. Prevention & Control, References.- Module 9_Birnaviruses.- Chapter 9.1. Background.- Chapter 9.2. History.- Chapter 9.3.Incidence and Prevalence.- Chapter 9.4. Diagnostic Techniques.- Chapter 9.5. Risk Factors.- Chapter 9.6. Transmission.- Chapter 9.7. Prevention & Control, References.- Module 10_Picobirnaviruses.- Chapter 10.1. Background.- Chapter 10.2. History.- Chapter 10.3. Incidence and Prevalence.- Chapter 10.4. Diagnostic Techniques.- Chapter 10.5. Risk Factors.- Chapter 10.6. Transmission.- Chapter 10.7. Prevention & Control, References.- Module 11_Rhabdoviruses.- Chapter 11.1. Background.- Chapter 11.2. History.- Chapter 11.3. Incidence and Prevalence.- Chapter 11.4. Diagnostic Techniques.- Chapter 11.5. Risk Factors.- Chapter 11.6. Transmission.- Chapter 11.7. Prevention & Control, References.- Module 12_Paramyxoviruses.- Chapter 12.1. Background.- Chapter 12.2. History.- Chapter 12.3. Incidence and Prevalence.- Chapter 12.4. Diagnostic Techniques.- Chapter 12.5. Risk Factors.- Chapter 12.6. Transmission.- Chapter 12.7. Prevention & Control, References.- Module 13_Orthomyxoviruses.- Chapter 13.1. Background.- Chapter 13.2. History.- Chapter 13.3. Incidence and Prevalence.- Chapter 13.4. Diagnostic Techniques.- Chapter 13.5. Risk Factors.- Chapter 13.6. Transmission.- Chapter 13.7. Prevention & Control, References.- Module 14_Picornaviruses.- Chapter 14.1. Background.- Chapter 14.2. History.- Chapter 14.3. Incidence and Prevalence.- Chapter 14.4. Diagnostic Techniques.- Chapter 14.5. Risk Factors.- Chapter 14.6. Transmission.- Chapter 14.7. Prevention & Control, References.- Module 15_Coronaviruses.- Chapter 15.1. Background.- Chapter 15.2. History.- Chapter 15.3. Incidence and Prevalence.- Chapter 15.4. Diagnostic Techniques.- Chapter 15.5. Risk Factors.- Chapter 15.6. Transmission.- Chapter 15.7. Prevention & Control, References.-Module 16_Flaviruses.- Chapter 16.1. Background.- Chapter 16.2.History.- Chapter 16.3. Incidence and Prevalence.- Chapter 16.4. Diagnostic Techniques.- Chapter 16.5. Risk Factors.- Chapter 16.6. Transmission.- Chapter 16.7. Prevention & Control, References.- Module 17_Equine viruses (Equine infectious Anaemia, West Nile, Equine Influenza).- Chapter 17.1. Background.- Chapter 17.2. History.- Chapter 17.3. Incidence and Prevalence.- Chapter 17.3. Diagnostic Techniques.- Chapter 17.4. Risk Factors.- Chapter 17.5. Transmission.- Chapter 17.6. Prevention & Control, References.- Module 18_Diagnostics.- Chapter 18.1. Background.- Chapter 18.2. Conventional Assays.- Chapter 18.3. Modern Assays.- Chapter 18.4. Future Questions.- Chapter 18.5. References.- Module 19_Vaccines.- Chapter 19.1. Background.- Chapter 19.1. Classical and modern approaches, Vaccine Administration.- Chapter 19.3. Mechanism of Action.- Chapter 19.4. Clinical Activity.- Chapter 19.5. Safety/Adverse Events.- Chapter 19.6. Future Questions.- Chapter 19.6. References.- Module 20_ Summary.
「Nielsen BookData」 より